Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Doxepin Hydrochloride Patent Expiration

Doxepin Hydrochloride is Used for treating insomnia. It was first introduced by Pfizer Laboratories Div Pfizer Inc in its drug Sinequan on Approved Prior to Jan 1, 1982. Other drugs containing Doxepin Hydrochloride are Doxepin Hydrochloride, Silenor, Zonalon. 40 different companies have introduced drugs containing Doxepin Hydrochloride.


Doxepin Hydrochloride Patents

Given below is the list of patents protecting Doxepin Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Silenor US8513299 Methods of using low-dose doxepin for the improvement of sleep Sep 07, 2030 Currax
Silenor US9532971 Low-dose doxepin formulations and methods of making and using the same Jun 01, 2029 Currax
Silenor US9107898 Methods of using low-dose doxepin for the improvement of sleep May 01, 2028 Currax
Silenor US10548871 Low-dose doxepin formulations and methods of making and using the same Apr 11, 2028 Currax
Silenor US11096920 Low-dose doxepin formulations and methods of making and using the same Apr 11, 2028 Currax
Silenor US9907780 Low-dose doxepin formulations and methods of making and using the same Apr 11, 2028 Currax
Silenor US11234954 Low-dose doxepin for treatment of sleep disorders in elderly patients Jan 18, 2028 Currax
Silenor US7915307 Methods of improving the pharmacokinetics of doxepin Aug 24, 2027 Currax
Silenor US10653660 Methods of improving the pharmacokinetics of doxepin Jul 20, 2027 Currax
Silenor US11110074 Methods of improving the pharmacokinetics of doxepin Jul 20, 2027 Currax
Silenor US9572814 Methods of improving the pharmacokinetics of doxepin Jul 20, 2027 Currax
Silenor US10238620 Methods of using low-dose doxepin for the improvement of sleep May 18, 2027 Currax
Silenor US10653662 Methods of using low-dose doxepin for the improvement of sleep May 18, 2027 Currax
Silenor US12083090 Methods of using low-dose doxepin for the improvement of sleep May 18, 2027 Currax
Silenor US9486437 Methods of using low-dose doxepin for the improvement of sleep May 18, 2027 Currax
Silenor US9861607 Methods of using low-dose doxepin for the improvement of sleep May 18, 2027 Currax
Silenor US6211229 Treatment of transient and short term insomnia Feb 17, 2020

(Expired)

 Currax
Silenor US5585115 Pharmaceutical excipient having improved compressability Jan 09, 2015

(Expired)

 Currax
Silenor US5725884 Pharmaceutical excipient having improved compressibility Jan 09, 2015

(Expired)

 Currax
Silenor US5866166 Pharmaceutical excipient having improved compressibility Jan 09, 2015

(Expired)

 Currax
Silenor US5948438 Pharmaceutical formulations having improved disintegration and/or absorptivity Jan 09, 2015

(Expired)

 Currax
Silenor US6103219 Pharmaceutical excipient having improved compressibility Jan 09, 2015

(Expired)

 Currax
Silenor US6217909 Pharmaceutical excipient having improved compressibility Jan 09, 2015

(Expired)

 Currax
Silenor US5502047 Treatment for insomnia Mar 26, 2013

(Expired)

 Currax



A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Doxepin Hydrochloride's patents.

Given below is the list recent legal activities going on the following patents of Doxepin Hydrochloride.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 8th Yr, Small Entity 19 Jun, 2024 US9532971
Payment of Maintenance Fee, 8th Yr, Small Entity 24 Apr, 2024 US9486437
Payment of Maintenance Fee, 4th Yr, Small Entity 01 Nov, 2023 US10653660
Payment of Maintenance Fee, 4th Yr, Small Entity 01 Nov, 2023 US10653662
Payment of Maintenance Fee, 4th Yr, Small Entity 19 Jul, 2023 US10548871
Payment of Maintenance Fee, 8th Yr, Small Entity 01 Feb, 2023 US9107898
Payment of Maintenance Fee, 4th Yr, Small Entity 14 Sep, 2022 US10238620
Payment of Maintenance Fee, 12th Yr, Small Entity 14 Sep, 2022 US7915307(Litigated)
Patent Issue Date Used in PTA Calculation
Critical
 01 Feb, 2022 US11234954
Recordation of Patent Grant Mailed
Critical
 01 Feb, 2022 US11234954


Doxepin Hydrochloride's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Doxepin Hydrochloride Generic API Manufacturers

Several generic applications have been filed for Doxepin Hydrochloride. The first generic version for Doxepin Hydrochloride was by Mylan Pharmaceuticals Inc and was approved on May 13, 1986. And the latest generic version is by Aurobindo Pharma Ltd and was approved on Jul 25, 2024.

Given below is the list of companies who have filed for Doxepin Hydrochloride generic, along with the locations of their manufacturing plants worldwide.


1. ACTAVIS ELIZABETH

Actavis Elizabeth Llc has filed for 2 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Actavis Elizabeth.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 3MG BASE

tablet Prescription ORAL AB Jul 26, 2013
EQ 6MG BASE

tablet Prescription ORAL AB Jul 26, 2013


Manufacturing Plant Locations
New

Actavis Elizabeth's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Actavis Elizabeth as present at those locations.

Country City Firm Name
United States
Elizabeth Actavis Elizabeth LLC, A Company of Teva





2. ADAPTIS

Adaptis Pharma Private Ltd has filed for 1 generic for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Adaptis.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 150MG BASE

capsule Discontinued ORAL N/A Apr 19, 2022





3. AIPING PHARM INC

Aiping Pharmaceutical Inc has filed for 5 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Aiping Pharm Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 10MG BASE

capsule Prescription ORAL AB Jul 28, 2020
EQ 25MG BASE

capsule Prescription ORAL AB Jul 28, 2020
EQ 50MG BASE

capsule Prescription ORAL AB Jul 28, 2020
EQ 75MG BASE

capsule Prescription ORAL AB Jul 28, 2020
EQ 100MG BASE

capsule Prescription ORAL AB Jul 28, 2020





4. AJANTA PHARMA LTD

Ajanta Pharma Ltd has filed for 7 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Ajanta Pharma Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 10MG BASE

capsule Prescription ORAL AB Sep 13, 2019
EQ 75MG BASE

capsule Prescription ORAL AB Sep 13, 2019
EQ 100MG BASE

capsule Prescription ORAL AB Sep 13, 2019
EQ 50MG BASE

capsule Prescription ORAL AB Sep 13, 2019
EQ 25MG BASE

capsule Prescription ORAL AB Sep 13, 2019
EQ 6MG BASE

tablet Discontinued ORAL N/A Jul 1, 2024
EQ 3MG BASE

tablet Discontinued ORAL N/A Jul 1, 2024


Manufacturing Plant Locations
New

Ajanta Pharma Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Ajanta Pharma Ltd as present at those locations.

Country City Firm Name
India
Aurangabad Ajanta Pharma Ltd.





5. ALEMBIC

Alembic Pharmaceuticals Ltd has filed for 5 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Alembic.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE

capsule Prescription ORAL AB Apr 21, 2021
EQ 50MG BASE

capsule Prescription ORAL AB Apr 21, 2021
EQ 25MG BASE

capsule Prescription ORAL AB Apr 21, 2021
EQ 10MG BASE

capsule Prescription ORAL AB Apr 21, 2021
EQ 75MG BASE

capsule Prescription ORAL AB Apr 21, 2021


Manufacturing Plant Locations
New

Alembic's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Alembic as present at those locations.

Country City Firm Name
India
Panchmahal Alembic Pharmaceuticals Limited
Vadodara Alembic Pharmaceuticals, Ltd
Vadodara Alembic Pharmaceuticals Ltd (API Division, Karakhadi)
Panelav Alembic Pharmaceuticals Limited
Vadodara Alembic Pharmaceuticals Ltd
Vadodara Alembic Pharmaceuticals Limited
Panchmahal Alembic Pharmaceuticals Limited (Units I and II)





6. AMNEAL

Amneal Pharmaceuticals Llc has filed for 1 generic for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Amneal.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5%

cream Prescription TOPICAL AB Aug 16, 2023


Manufacturing Plant Locations
New

Amneal's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Amneal as present at those locations.

Country City Firm Name
United States
Branchburg Amneal Pharmaceuticals, LLC
Hauppauge Amneal Pharmaceuticals of New York, LLC
Paterson Amneal Pharmaceuticals, Llc
Brookhaven Amneal Pharmaceuticals of New York, LLC
East Hanover Amneal Pharmaceuticals LLC
Piscataway Amneal Pharmaceuticals, LLC
Bridgewater Amneal Complex Products Research LLC
Glasgow Amneal Pharmaceuticals LLC
India
Hyderabad Amneal Oncology Private Limited
Matoda Amneal Pharmaceuticals Private Ltd.
Ahmedabad Amneal Pharmaceuticals Private Ltd.
Tal Bavla, Ahmedabad Amneal Pharmaceuticals Pvt. Ltd.





7. AMNEAL PHARMS CO

Amneal Pharmaceuticals Co Gmbh has filed for 5 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Amneal Pharms Co.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 25MG BASE

capsule Prescription ORAL AB Jun 28, 2017
EQ 10MG BASE

capsule Prescription ORAL AB Jun 28, 2017
EQ 50MG BASE

capsule Prescription ORAL AB Jun 28, 2017
EQ 75MG BASE

capsule Prescription ORAL AB Jun 28, 2017
EQ 100MG BASE

capsule Prescription ORAL AB Jun 28, 2017





8. APPCO

Appco Pharma Llc has filed for 5 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Appco.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 50MG BASE

capsule Prescription ORAL AB Apr 1, 2021
EQ 25MG BASE

capsule Prescription ORAL AB Apr 1, 2021
EQ 100MG BASE

capsule Prescription ORAL AB Apr 1, 2021
EQ 75MG BASE

capsule Prescription ORAL AB Apr 1, 2021
EQ 10MG BASE

capsule Prescription ORAL AB Apr 1, 2021


Manufacturing Plant Locations
New

Appco's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Appco as present at those locations.

Country City Firm Name
United States
Somerset Appco Pharma, LLC
Piscataway Appco Pharma LLC





9. AUROBINDO PHARMA LTD

Aurobindo Pharma Ltd has filed for 7 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 75MG BASE

capsule Prescription ORAL AB Mar 27, 2019
EQ 25MG BASE

capsule Prescription ORAL AB Mar 27, 2019
EQ 10MG BASE

capsule Prescription ORAL AB Mar 27, 2019
EQ 100MG BASE

capsule Prescription ORAL AB Mar 27, 2019
EQ 50MG BASE

capsule Prescription ORAL AB Mar 27, 2019
EQ 6MG BASE

tablet Discontinued ORAL N/A Jul 25, 2024
EQ 3MG BASE

tablet Discontinued ORAL N/A Jul 25, 2024


Manufacturing Plant Locations
New

Aurobindo Pharma Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma Ltd as present at those locations.

Country City Firm Name
India
Medchal Aurobindo Pharma Ltd





10. CHARTWELL RX

Chartwell Rx Sciences Llc has filed for 5 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Chartwell Rx.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 10MG BASE

capsule Prescription ORAL AB Sep 4, 2020
EQ 100MG BASE

capsule Prescription ORAL AB Sep 4, 2020
EQ 75MG BASE

capsule Prescription ORAL AB Sep 4, 2020
EQ 25MG BASE

capsule Prescription ORAL AB Sep 4, 2020
EQ 50MG BASE

capsule Prescription ORAL AB Sep 4, 2020





11. DAVA PHARMS INC

Dava Pharmaceuticals Inc has filed for 6 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Dava Pharms Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 50MG BASE

capsule Discontinued ORAL N/A Jan 5, 1988
EQ 25MG BASE

capsule Discontinued ORAL N/A Jan 5, 1988
EQ 10MG BASE

capsule Discontinued ORAL N/A Jan 5, 1988
EQ 150MG BASE

capsule Discontinued ORAL N/A Jan 5, 1988
EQ 100MG BASE

capsule Discontinued ORAL N/A Jan 5, 1988
EQ 75MG BASE

capsule Discontinued ORAL N/A Jan 5, 1988





12. ENDO OPERATIONS

Endo Operations Ltd has filed for 6 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Endo Operations.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 25MG BASE

capsule Discontinued ORAL N/A Nov 9, 1987
EQ 100MG BASE

capsule Discontinued ORAL N/A Nov 9, 1987
EQ 10MG BASE

capsule Discontinued ORAL N/A Nov 9, 1987
EQ 50MG BASE

capsule Discontinued ORAL N/A Nov 9, 1987
EQ 75MG BASE

capsule Discontinued ORAL N/A Nov 9, 1987
EQ 150MG BASE

(reference standard)

capsule Prescription ORAL AB Nov 9, 1987





13. EPIC PHARMA LLC

Epic Pharma Llc has filed for 5 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Epic Pharma Llc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 25MG BASE

capsule Prescription ORAL AB Oct 16, 2020
EQ 10MG BASE

capsule Prescription ORAL AB Oct 16, 2020
EQ 100MG BASE

capsule Prescription ORAL AB Oct 16, 2020
EQ 75MG BASE

capsule Prescription ORAL AB Mar 3, 2022
EQ 50MG BASE

capsule Prescription ORAL AB Mar 3, 2022





14. JUBILANT CADISTA

Jubilant Cadista Pharmaceuticals Inc has filed for 5 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Jubilant Cadista.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 25MG BASE

capsule Prescription ORAL AB Mar 14, 2022
EQ 100MG BASE

capsule Prescription ORAL AB Mar 14, 2022
EQ 10MG BASE

capsule Prescription ORAL AB Mar 14, 2022
EQ 75MG BASE

capsule Prescription ORAL AB Mar 14, 2022
EQ 50MG BASE

capsule Prescription ORAL AB Mar 14, 2022


Manufacturing Plant Locations
New

Jubilant Cadista's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Jubilant Cadista as present at those locations.

Country City Firm Name
United States
Salisbury Jubilant Cadista Pharmaceuticals, Inc.





15. LANNETT CO INC

Lannett Co Inc has filed for 6 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Lannett Co Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 10MG BASE/ML

(reference standard)

concentrate Prescription ORAL N/A Dec 29, 1998
EQ 10MG BASE

capsule Discontinued ORAL N/A Jul 24, 2020
EQ 75MG BASE

capsule Discontinued ORAL N/A Jul 24, 2020
EQ 50MG BASE

capsule Discontinued ORAL N/A Jul 24, 2020
EQ 25MG BASE

capsule Discontinued ORAL N/A Jul 24, 2020
EQ 100MG BASE

capsule Discontinued ORAL N/A Jul 24, 2020





16. LEADING

Leading Pharma Llc has filed for 5 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Leading.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 10MG BASE

capsule Prescription ORAL AB Mar 9, 2021
EQ 25MG BASE

capsule Prescription ORAL AB Mar 9, 2021
EQ 50MG BASE

capsule Prescription ORAL AB Mar 9, 2021
EQ 75MG BASE

capsule Prescription ORAL AB Mar 9, 2021
EQ 100MG BASE

capsule Prescription ORAL AB Mar 9, 2021


Manufacturing Plant Locations
New

Leading's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Leading as present at those locations.

Country City Firm Name
United States
Fairfield Leading Pharma, LLC
Seattle Leading Edge Jet Center





17. MANKIND PHARMA

Mankind Pharma Ltd has filed for 5 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Mankind Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 10MG BASE

capsule Prescription ORAL AB Feb 9, 2022
EQ 25MG BASE

capsule Prescription ORAL AB Feb 9, 2022
EQ 100MG BASE

capsule Prescription ORAL AB Feb 9, 2022
EQ 75MG BASE

capsule Prescription ORAL AB Feb 9, 2022
EQ 50MG BASE

capsule Prescription ORAL AB Feb 9, 2022


Manufacturing Plant Locations
New

Mankind Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Mankind Pharma as present at those locations.

Country City Firm Name
India
Imt Manesar Mankind Pharma Limited
Paonta Sahib Mankind Pharma Limited





18. MICRO LABS

Micro Labs Ltd has filed for 5 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Micro Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 10MG BASE

capsule Prescription ORAL AB Jun 27, 2023
EQ 25MG BASE

capsule Prescription ORAL AB Jun 27, 2023
EQ 50MG BASE

capsule Prescription ORAL AB Jun 27, 2023
EQ 100MG BASE

capsule Prescription ORAL AB Jun 27, 2023
EQ 75MG BASE

capsule Prescription ORAL AB Jun 27, 2023


Manufacturing Plant Locations
New

Micro Labs's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Micro Labs as present at those locations.

Country City Firm Name
India
Bangalore Micro Labs Limited
Bengaluru Micro Labs Limited, Central Analytical Laboratory
Bengaluru Micro Labs Limited
Verna Micro Labs Limited





19. MSN

Msn Laboratories Private Ltd has filed for 7 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Msn.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 25MG BASE

capsule Prescription ORAL AB Jun 24, 2022
EQ 10MG BASE

capsule Prescription ORAL AB Jun 24, 2022
EQ 50MG BASE

capsule Prescription ORAL AB Jun 24, 2022
EQ 75MG BASE

capsule Prescription ORAL AB Jun 24, 2022
EQ 100MG BASE

capsule Prescription ORAL AB Jun 24, 2022
EQ 3MG BASE

tablet Prescription ORAL BX Apr 3, 2023
EQ 6MG BASE

tablet Prescription ORAL BX Apr 3, 2023


Manufacturing Plant Locations
New

Msn's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Msn as present at those locations.

Country City Firm Name
India
Medak MSN LIFE SCIENCES PRIVATE LIMITED
Isnapur MSN Laboratories Private Limited, Unit-II
Rangareddy District MSN Laboratories Private Limited
Sangareddy MSN Pharmachem Private Limited
Sangareddy MSN Laboratories Private Ltd.
Sangareddy MSN Laboratories Private Limited, R&D Center
Rangareddy District MSN Laboratories Private Limited (Formulations Division, Unit-II)
Yadadri Bhuvanagiri District MSN Organics Private Limited
Jinnaram, Sangareddy MSN Laboratories Private Limited - Formulations Division
Kamareddy MSN Life Sciences Private Limited
United States
Piscataway MSN PHARMACEUTICALS INC





20. MYLAN PHARMS INC

Mylan Pharmaceuticals Inc has filed for 5 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Mylan Pharms Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 25MG BASE

(reference standard)

capsule Prescription ORAL AB May 13, 1986
EQ 50MG BASE

capsule Prescription ORAL AB May 13, 1986
EQ 10MG BASE

capsule Prescription ORAL AB May 13, 1986
EQ 75MG BASE

capsule Prescription ORAL AB May 13, 1986
EQ 100MG BASE

(reference standard)

capsule Prescription ORAL AB May 13, 1986





21. PAR PHARM

Par Pharmaceutical Inc has filed for 5 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Par Pharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 25MG BASE

capsule Discontinued ORAL N/A Nov 9, 1987
EQ 50MG BASE

capsule Discontinued ORAL N/A Nov 9, 1987
EQ 75MG BASE

capsule Discontinued ORAL N/A Nov 9, 1987
EQ 150MG BASE

capsule Prescription ORAL N/A Nov 9, 1987
EQ 10MG BASE

capsule Discontinued ORAL N/A Nov 9, 1987


Manufacturing Plant Locations
New

Par Pharm's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Par Pharm as present at those locations.

Country City Firm Name
United States
Stratford Par Pharmaceutical Inc.
Hauppauge Par Pharmaceuticals





22. PHARM ASSOC

Pharmaceutical Assoc Inc has filed for 1 generic for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Pharm Assoc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 10MG BASE/ML

concentrate Discontinued ORAL N/A Jan 15, 2004





23. PHARMOBEDIENT CNSLTG

Pharmobedient Consulting has filed for 1 generic for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Pharmobedient Cnsltg.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 10MG BASE/ML

concentrate Discontinued ORAL N/A Jul 20, 1988





24. PTS CONSULTING

Pts Consulting Llc has filed for 5 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Pts Consulting.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 75MG BASE

capsule Prescription ORAL AB Aug 21, 2023
EQ 100MG BASE

capsule Prescription ORAL AB Aug 21, 2023
EQ 10MG BASE

capsule Prescription ORAL AB Aug 21, 2023
EQ 25MG BASE

capsule Prescription ORAL AB Aug 21, 2023
EQ 50MG BASE

capsule Prescription ORAL AB Aug 21, 2023





25. PUREPAC PHARM

Purepac Pharmaceutical Co has filed for 6 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Purepac Pharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 75MG BASE

capsule Discontinued ORAL N/A Sep 8, 1988
EQ 100MG BASE

capsule Discontinued ORAL N/A Sep 8, 1988
EQ 150MG BASE

capsule Discontinued ORAL N/A Sep 8, 1988
EQ 25MG BASE

capsule Discontinued ORAL N/A Dec 28, 1990
EQ 50MG BASE

capsule Discontinued ORAL N/A Dec 28, 1990
EQ 10MG BASE

capsule Discontinued ORAL N/A Dec 28, 1990





26. QUANTUM PHARMICS

Quantum Pharmics Ltd has filed for 6 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Quantum Pharmics.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 75MG BASE

capsule Discontinued ORAL N/A Sep 29, 1987
EQ 50MG BASE

capsule Discontinued ORAL N/A Sep 29, 1987
EQ 10MG BASE

capsule Discontinued ORAL N/A Sep 29, 1987
EQ 25MG BASE

capsule Discontinued ORAL N/A Sep 29, 1987
EQ 150MG BASE

capsule Discontinued ORAL N/A Mar 15, 1989
EQ 100MG BASE

capsule Discontinued ORAL N/A Mar 15, 1989





27. RK PHARMA

Rk Pharma Inc has filed for 2 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Rk Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 3MG BASE

tablet Prescription ORAL AB Jan 20, 2016
EQ 6MG BASE

tablet Prescription ORAL AB Jan 20, 2016


Manufacturing Plant Locations
New

Rk Pharma's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Rk Pharma as present at those locations.

Country City Firm Name
United States
Pearl River RK Pharma Inc.





28. SANDOZ

Sandoz Inc has filed for 5 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Sandoz.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 75MG BASE

capsule Discontinued ORAL N/A May 15, 1986
EQ 25MG BASE

capsule Discontinued ORAL N/A May 15, 1986
EQ 50MG BASE

capsule Discontinued ORAL N/A May 15, 1986
EQ 100MG BASE

capsule Discontinued ORAL N/A Mar 2, 1987
EQ 10MG BASE

capsule Discontinued ORAL N/A Mar 2, 1987


Manufacturing Plant Locations
New

Sandoz's manufacturing plants are situated in 4 countries - Austria, United States, Spain, India. Given below are the details of these plant locations as well as the firm names of Sandoz as present at those locations.

Country City Firm Name
Austria
Kundl Sandoz GmbH
Langkampfen Sandoz GmbH
United States
Princeton Sandoz Inc
East Hanover Sandoz Incorporated
Spain
Les Franqueses Del Valles Sandoz Industrial Products S.A.
Palafolls Sandoz Industrial Products, S.A.
India
Navi Mumbai Sandoz Private Limited





29. STRIDES PHARMA

Strides Pharma Global Pte Ltd has filed for 2 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Strides Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 3MG BASE

tablet Prescription ORAL AB Jul 24, 2020
EQ 6MG BASE

tablet Prescription ORAL AB Jul 24, 2020


Manufacturing Plant Locations
New

Strides Pharma's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Strides Pharma as present at those locations.

Country City Firm Name
United States
Chestnut Ridge Strides Pharma, Inc.
East Brunswick Strides Pharma Inc.
India
Bangalore Strides Pharma Science Limited
Puducherry Strides Pharma Science Limited





30. SUN PHARM INDUSTRIES

Sun Pharmaceutical Industries Inc has filed for 4 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Sun Pharm Industries.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 75MG BASE

capsule Discontinued ORAL N/A Feb 18, 1988
EQ 50MG BASE

capsule Discontinued ORAL N/A Feb 18, 1988
EQ 25MG BASE

capsule Discontinued ORAL N/A Feb 18, 1988
EQ 100MG BASE

capsule Discontinued ORAL N/A Feb 18, 1988





31. TARO

Taro Pharmaceutical Industries Ltd has filed for 5 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Taro.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 25MG BASE

capsule Prescription ORAL AB Jul 1, 2020
EQ 75MG BASE

capsule Prescription ORAL AB Jul 1, 2020
EQ 50MG BASE

capsule Prescription ORAL AB Jul 1, 2020
EQ 10MG BASE

capsule Prescription ORAL AB Jul 1, 2020
EQ 100MG BASE

capsule Prescription ORAL AB Jul 1, 2020


Manufacturing Plant Locations
New

Taro's manufacturing plants are situated in 3 countries - United States, Israel, Canada. Given below are the details of these plant locations as well as the firm names of Taro as present at those locations.

Country City Firm Name
United States
Honolulu Taro Delight, LLC
Hawthorne Taro Pharmaceuticals U.S.A., Inc.
Israel
Haifa Taro Pharmaceutical Industries, Ltd.
Canada
Brampton Taro Pharmaceuticals Inc.





32. TEVA PHARMS

Teva Pharmaceuticals Development Inc has filed for 2 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Teva Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 10MG BASE/ML

concentrate Discontinued ORAL N/A Nov 9, 1987
5%

cream Prescription TOPICAL AB Feb 17, 2023





33. VELZEN PHARMA PVT

Velzen Pharma Pvt Ltd has filed for 1 generic for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Velzen Pharma Pvt.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 150MG BASE

capsule Prescription ORAL AB Mar 1, 2021





34. WATSON LABS

Watson Laboratories Inc has filed for 6 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Watson Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 25MG BASE

capsule Discontinued ORAL N/A Mar 29, 1991
EQ 50MG BASE

capsule Discontinued ORAL N/A Apr 30, 1987
EQ 100MG BASE

capsule Discontinued ORAL N/A Apr 30, 1987
EQ 10MG BASE

capsule Discontinued ORAL N/A Mar 29, 1991
EQ 75MG BASE

capsule Discontinued ORAL N/A Feb 9, 1988
EQ 150MG BASE

capsule Discontinued ORAL N/A Feb 9, 1988





35. WATSON LABS TEVA

Watson Laboratories Inc An Indirect Wholly Owned Sub Of Teva Pharmaceuticals Usa Inc has filed for 1 generic for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Watson Labs Teva.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 50MG BASE

capsule Discontinued ORAL N/A Mar 29, 1991





36. ZYDUS LIFESCIENCES

Zydus Lifesciences Ltd has filed for 8 different strengths of generic version for Doxepin Hydrochloride. Given below are the details of the strengths of this generic introduced by Zydus Lifesciences.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 150MG BASE

capsule Prescription ORAL BX Mar 21, 2023
EQ 100MG BASE

capsule Prescription ORAL BX Mar 23, 2023
EQ 25MG BASE

capsule Prescription ORAL BX Mar 23, 2023
EQ 10MG BASE

capsule Prescription ORAL BX Mar 23, 2023
EQ 50MG BASE

capsule Prescription ORAL BX Mar 23, 2023
EQ 75MG BASE

capsule Prescription ORAL BX Mar 23, 2023
EQ 3MG BASE

tablet Prescription ORAL AB Aug 16, 2023
EQ 6MG BASE

tablet Prescription ORAL AB Aug 16, 2023


Manufacturing Plant Locations
New

Zydus Lifesciences's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Zydus Lifesciences as present at those locations.

Country City Firm Name
India
Matoda Zydus Lifesciences Limited
Jarod Zydus Lifesciences Limited
Ankleshwar Zydus Lifesciences Limited
Thane Zydus Lifesciences Limited
District Solan Zydus Lifesciences Limited
Ahmedabad Zydus Lifesciences Limited
Dabhasa Zydus Lifesciences Limited
Moraiya, Ahmedabad Zydus Lifesciences Limited
Ahmedabad ZYDUS LIFESCIENCES LIMITED